Diabetes Mellitus, Noninsulin Dependent Completed Phase 2 Trials for Remogliflozin etabonate (DB12935)

Also known as: Noninsulin-dependent Diabetes Mellitus / Non-Insulin Dependent Diabetes Mellitus / Diabetes Mellitus, Noninsulin-Dependent / Non-Insulin-Dependent Diabetes Mellitus / Diabetes Mellitus, Non-Insulin-Dependent / Diabetes mellitus non-insulin-dependent / NIDDM / Diabetes mellitus: [adult onset] or [noninsulin dependent] / Diabetes mellitus type 2 (disorder) / Diabetes mellitus: [adult onset, with no mention of complication] or [maturity onset] or [non-insulin dependent] / Type II diabetes mellitus / Type 2 diabetes mellitus / Diabetes Mellitus, Type 2 / Diabetes mellitus non insulin-dep / Maturity onset diabetes / Diabetes mellitus maturity onset

IndicationStatusPhase
DBCOND0043945 (Diabetes Mellitus, Noninsulin Dependent)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00291356GSK189075, GW869682 Or Placebo In Type 2 Diabetic PatientsTreatment